Tag Archives: Biotech

Publications

25 Mar

Carapinha, J. (2000) Continuing Professional Development in Human Resource Management. Journal of Modern Pharmacy, 7 (10), 1-6. Carapinha, J. (2003) Rational Self-Medication within a South African Context. The Journal of Modern Pharmacy, February 2003. Carapinha, J. (2005) Ethical Decision Making in Managed Health Care. South African Pharmaceutical Journal, 72 (2). Carapinha, J. (2005) Evidence-Based Pharmacy Practice. […]

Reinventing Technology Assessment for the 21st Century

13 May

A new report from the Science and Technology Innovation Program at the Woodrow Wilson International Center for Scholars defines the criteria for a new technology assessment function in the United States. The report, Reinventing Technology Assessment: A 21st Century Model, emphasizes the need to incorporate citizen-participation methods to complement expert analysis. Government policymakers, businesses, non-governmental […]

Why Pharma needs a New Commercial Model

06 Apr

This  article by Huw Tippett reminds me so much of discussions during the 90’s when pharmaceutical companies were under considerable pressure from governments to lower prices. Much of this gave rise to alternative business models and this is partly the reason for the risk-sharing models /pay for performance discuss today. Tippett’s article discusses an inflection […]

Singapore Welcomes Scientific Talent

23 Mar

Asia has experienced rapid growth in the biomedical sciences and pharmaceutical fields. Within the last decade, Singapore has established itself as a global scientific powerhouse, attracting leading companies. The city-state has built up a reputation for biomedical sciences innovation in addition to being a global financial and business hub. Singapore’s biomedical sciences industry contributes 4.1% […]

S’pore’s biomedical output grew to $21b last year

18 Mar

SINGAPORE’S biomedical manufacturing output grew at a robust pace last year to reach $21 billion and employed 13,000 people, the Economic Development Board (EDB) said yesterday. According to Spring Singapore, last year’s production outpaced the previous year’s $19 billion and a value-add of $10.6 billion. Last year, the sector attracted cumulative capital of $1.2 billion […]

The Next Big Opportunity for Big Pharma Is BRIC

14 Mar

The pharmaceutical landscape is rapidly changing on a global scale. Big Pharma no longer wants to dominate just in the US market — it’s increasingly chasing opportunities in new emerging markets like China, India, and Africa. The latest company to dip its toe in the emerging tide is AstraZeneca (AZN). The Anglo-Swedish pharmaceutical company announced […]

Bayer Schering bares $1.4-billion Asian expansion

14 Mar

SINGAPORE – Bayer Schering Pharma Asia Pacific is aiming to grow its business faster than the industry average this year after reporting a 13 percent improvement in sales last year to EUR 1.04 billion, ($1.41 billion) from EUR 910 million ($1.237.6 billion) in 2008, despite the global crisis. In a press briefing here on Friday, […]

Research and Markets – Biotechnology Sector

09 Mar

The US biotechnology industry includes about 1,500 companies with combined annual revenue of about $70 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. COMPETITIVE LANDSCAPE Demand for biotechnology research in the […]

97 more Philippines price cuts this month

03 Mar

In the Philippines, the prices of at least 97 medicines to treat cancer, asthma and other common conditions will be reduced by 50% on average on March 31, saving patients at least 1 billion pesos ($22 million) a year, the government has said. 11 pharmaceutical manufacturers have agreed to cut their prices in this latest […]

Carapinha Logo